Efficacy of a combination of HBV RNA and HBeAg in predicting HBeAg seroconversion in patients treated with entecavir for 144 weeks-Reference-Cited by-同舟云学术

Efficacy of a combination of HBV RNA and HBeAg in predicting HBeAg seroconversion in patients treated with entecavir for 144 weeks

Published:2020-10 Issue: Volume:99 Page:171-178
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Wang Xiaomei,Wang Zhongfeng,Chi Xiumei,Wu Ruihong,Jin Qinglong,Xu Hongqin,Gao Xiuzhu,Yu Lei,Chen Yuping,Shang Jia,Liu Longgen,Zhang Shuqin,Jiang Yongfang,Zhang Mingxiang,Tong Qiaoxia,Zhang Lunli,Tan Youwen,Ma Anlin,Dang Shuangsuo,Xu Bin,Jin Zhenjing,Li Jia,Li Xiaobo,Lu Fengmin,Niu Junqi

Funder

State Key Science & Technology Project for Infectious Diseases

Program for JLU Science and Technology Innovative Research Team

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference28 articles.

1. Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine;Bowden;World J Gastroenterol,2015

2. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B;Chang;Hepatology,2010

3. EASL clinical practice guidelines: management of chronic hepatitis B virus infection;European Association For The Study Of The Liver;J Hepatol,2012

4. Hepatitis B virus infection—natural history and clinical consequences;Ganem;N Engl J Med,2004

5. Serum hepatitis B virus DNA, RNA, and HBsAg: which correlated better with intrahepatic covalently closed circular DNA before and after nucleos(t)ide analogue treatment?;Gao;J Clin Microbiol,2017

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dopamine Inhibits the Expression of Hepatitis B Virus Surface and e Antigens by Activating the JAK/STAT Pathway and Upregulating Interferon-stimulated Gene 15 Expression;Journal of Clinical and Translational Hepatology;2024-04-30

2. Biogenesis of serum HBV RNA and clinical phenomena of serum HBV RNA in chronic hepatitis B patients before and after receiving nucleos(t)ide analogues therapy;Journal of Viral Hepatitis;2024-02-08

3. HBV pregenome RNA as a predictor of spontanous HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients;BMC Gastroenterology;2023-11-09

4. Sera of Individuals Chronically Infected with Hepatitis B Virus (HBV) Contain Diverse RNA Types Produced by HBV Replication or Derived from Integrated HBV DNA;Journal of Virology;2023-03-30

5. Values of Serum HBsAg and HBeAg Levels for Virological Response of Patients with HBV-Related Liver Cirrhosis Treated by Entecavir;Clinical Laboratory;2023